PGN36
Product Specifications
UNSPSC Description
PGN36 (Compound 18) is a selective cannabinoid CB2 receptor (CB2R) antagonist with a Ki of 0.09 µM[1].
Target Antigen
Cannabinoid Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein;Neuronal Signaling
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/pgn36.html
Solubility
DMSO : 12.5 mg/mL (ultrasonic;warming;heat to 60°C)
Smiles
O=[N+](C1=CC2=C(N(CC3=CC=CC=C3)N=C2OCC4CCCCC4)C=C1)[O-]
Molecular Weight
365.43
References & Citations
[1]González-Naranjo P, et al. New cannabinoid receptor antagonists as pharmacological tool. Bioorg Med Chem. 2020 Oct 1;28(19):115672.
Shipping Conditions
Blue Ice
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-146134/PGN36-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-146134/PGN36-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
1564253-75-3
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Multiplex Assay Kit for Calcium/Calmodulin Dependent Protein Kinase Kinase 2 (CAMKK2), etc. by FLIA (Flow Luminescence Immunoassay)
